Skip to content

Jenny L Wiley

27 papers in the library · 233 citations · publishing 2003-2024

Papers

Sort Most recent Most cited

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 8, 2024 Jenny L Wiley, Julie A. Marusich, Bruce E. Blough et al.

The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9-Tetrahydrocannabinol (Δ9-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used...

Experimenter administered Δ9-THC decreases nicotine self-administration in a rat model.

Pharmacology, Biochemistry, and Behavior October 2023 Antony D Abraham, Jenny L Wiley, Julie A. Marusich

The co-use of nicotine and cannabis has been steadily rising in the United States. Rodent studies suggest that delta-9-tetrahydrocannabinol (THC) could increase addictive qualities of nicotine, but whether repeated THC exposure alters self-administration of nicotine has not been tested. We hypothesized that THC would increase the reinforcing effects of nicotine and alter nicotine intake. Adult...

Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats.

Drug and Alcohol Dependence January 1, 2019 Charlotte E Farquhar, Christopher S Breivogel, Thomas F Gamage et al.

The recent NIH mandate to consider sex as a biological variable in preclinical research has focused attention on delineation of sex differences in behavior. To investigate mechanisms underlying sex differences in Δ9-tetrahydrocannabinol (THC) effects, we examined the effects of sex and gonadal hormones on CB1 receptors in cerebellum, hippocampus, prefrontal cortex, and striatum. Adult...

Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Neuropharmacology July 15, 2018 Daniel G Barrus, Timothy W Lefever, Jenny L Wiley

Edible cannabis-infused products are an increasingly popular method of using cannabis in the United States. Yet, preclinical research to determine mechanisms underlying abuse of Δ9-tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis, has focused primarily on the effects of parenteral administration. The purpose of this study was to examine the rewarding and aversive...

DOI: 10.1016/j.neuropharm.2018.04.018 (opens in new tab) Full text (opens in new tab) Cannabinoid Delta-9-tetrahydrocannabinol Oral Self-administration +1

Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Neuropharmacology May 15, 2018 Julie A. Marusich, Jenny L Wiley, Timothy W Lefever et al.

Diversion of synthetic cannabinoids from the lab to drugs of abuse has become increasingly prevalent in recent years. Moreover, as earlier synthetic cannabinoids were banned, manufacturers introduced a new supply of novel compounds to serve as replacements. Hence, the chemical diversity of synthetic cannabinoid analogs has also rapidly increased. The present study examined 8 new synthetic...

DOI: 10.1016/j.neuropharm.2017.10.041 (opens in new tab) Full text (opens in new tab) Abuse liability Drug discrimination Receptor binding Synthetic cannabinoids +1

Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.

Current Topics in Behavioral Neurosciences 2018 Jenny L Wiley, R Allen Owens, Aron H Lichtman

Psychoactive cannabinoids from the marijuana plant (phytocannabinoids), from the body (endocannabinoids), and from the research lab (synthetic cannabinoids) produce their discriminative stimulus effects by stimulation of CB1 receptors in the brain. Early discrimination work with phytocannabinoids confirmed that Δ9-tetrahydrocannabinol (Δ9-THC) is the primary psychoactive constituent of the...

DOI: 10.1007/7854_2016_24 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol Anandamide Endocannabinoids Faah inhibitors +3

Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.

Neuropharmacology October 2017 Robert A Owens, Mohammed A Mustafa, Bogna M Ignatowska-Jankowska et al.

Substantial challenges exist for investigating the cannabinoid receptor type 1 (CB1)-mediated discriminative stimulus effects of the endocannabinoids, 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (anandamide; AEA), compared with exogenous CB1 receptor agonists, such as Δ9-tetrahydrocannabinol (THC) and the synthetic cannabinoid CP55,940. Specifically, each endocannabinoid is...

DOI: 10.1016/j.neuropharm.2017.06.032 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol 2-ag Cp55,940 pubchem cid Cannabinoid-1 cb1 receptor Diazepam pubchem cid +13

Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.

Drug and Alcohol Dependence March 1, 2017 Jenny L Wiley, Timothy W Lefever, Julie A. Marusich et al.

Women report greater sensitivity to the subjective effects of Δ9-tetrahydrocannabinol (THC). Similarly, female rodents tend to be more sensitive to some pharmacological effects of THC and synthetic cannabinoids. This study examined sex differences in discriminative stimulus and response rate effects of THC and synthetic cannabinoids in rats. A cumulative dosing THC discrimination procedure was...

Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.

Current Topics in Behavioral Neurosciences 2017 Jenny L Wiley, Julie A. Marusich, Brian F Thomas

Originally developed as research tools for use in structure-activity relationship studies, synthetic cannabinoids contributed to significant scientific advances in the cannabinoid field. Unfortunately, a subset of these compounds was diverted for recreational use beginning in the early 2000s. As these compounds were banned, they were replaced with additional synthetic cannabinoids with...

Tasty THC: Promises and Challenges of Cannabis Edibles

November 15, 2016 Daniel G Barrus, Kristen Capogrossi, Sheryl Cates et al.

Food products containing cannabis extract (edibles) have emerged as a popular and lucrative facet of the legalized market for both recreational and medicinal cannabis. The many formulations of cannabis extracts used in edibles present a unique regulatory challenge for policy makers. Though edibles are often considered a safe, discreet, and effective means of attaining the therapeutic and/or...

Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.

Behavioural Pharmacology August 2016 Jenny L Wiley, Timothy W Lefever, Nikita S Pulley et al.

Incomplete overlap in the discriminative stimulus effects of Δ-tetrahydrocannabinol (THC) and the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol has been reported in food-reinforced tasks. The aim of this study was to examine cannabinoid discriminative stimulus effects in a nonappetitive procedure. Adult male mice lacking the gene for AEA's major metabolic enzyme, fatty acid...

Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.

Journal of Pharmacology and Experimental Therapeutics August 2016 Robert A Owens, Bogna M Ignatowska-Jankowska, Mohammed A Mustafa et al.

Whereas the inhibition of fatty acid amide hydrolase (FAAH) or monoacylglycerol lipase (MAGL), the respective major hydrolytic enzymes of N-arachidonoyl ethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), elicits no or partial substitution for Δ(9)-tetrahydrocannabinol (THC) in drug-discrimination procedures, combined inhibition of both enzymes fully substitutes for THC, as well as produces a...

Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.

Neuropharmacology June 2015 D Matthew Walentiny, Robert E Vann, Jenny L Wiley

A number of studies have examined the ability of the endogenous cannabinoid anandamide to elicit Δ(9)-tetrahydrocannabinol (THC)-like subjective effects, as modeled through the THC discrimination paradigm. In the present study, we compared transgenic mice lacking fatty acid amide hydrolase (FAAH), the enzyme primarily responsible for anandamide catabolism, to wildtype counterparts in a THC...

DOI: 10.1016/j.neuropharm.2015.02.004 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol Anandamide Drug discrimination Rimonabant +1

Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

Journal of Neuroscience November 12, 2014 Michael H. Baumann, Ernesto Solis, Lucas R. Watterson et al. 157 citations

The abuse of synthetic psychoactive substances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., "bath salts") and synthetic cannabinoids (i.e.,...

DOI: 10.1523/jneurosci.3223-14.2014 (opens in new tab) Full text (opens in new tab) MDMA Synthetic cannabinoids Designer drug Recreational drug +4

Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.

Pharmacology, Biochemistry, and Behavior September 2014 Jenny L Wiley, Timothy W Lefever, Ricardo A Cortes et al.

Synthetic indole-derived cannabinoids, originally developed to probe cannabinoid CB1 and CB2 receptors, have become widely abused for their marijuana-like intoxicating properties. The present study examined the effects of indole-derived cannabinoids in rats trained to discriminate Δ(9)-tetrahydrocannabinol (Δ(9)-THC) from vehicle. In addition, the effects of Δ(9)-THC in rats trained to...

DOI: 10.1016/j.pbb.2014.05.016 (opens in new tab) Full text (opens in new tab) Discriminative stimulus Jwh-018 Jwh-073 Jwh-210 +2

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

European Journal of Pharmacology August 15, 2014 Jenny L Wiley, D Matthew Walentiny, M Jerry Wright et al.

The mechanism through which marijuana produces its psychoactive effects is Δ(9)-tetrahydrocannabinol (THC)-induced activation of cannabinoid CB1 receptors. These receptors are normally activated by endogenous lipids, including anandamide and 2-arachidonoyl glycerol (2-AG). A logical "first step" in determination of the role of these endocannabinoids in THC׳s psychoactive effects is to...

DOI: 10.1016/j.ejphar.2014.05.013 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol Anandamide Jzl184 Pf3845 +2

Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Neuropharmacology December 2013 Jenny L Wiley, Julie A. Marusich, Timothy W Lefever et al.

Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences. As compounds that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compounds have appeared on the drug market. Two tetramethylcyclopropyl ketone indoles, UR-144...

DOI: 10.1016/j.neuropharm.2013.07.022 (opens in new tab) Full text (opens in new tab) Abuse liability Delta-9-tetrahydrocannabinol Drug discrimination Synthetic cannabinoids +2

3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.

Journal of Pharmacology and Experimental Therapeutics February 2012 Jenny L Wiley, Dana E Selley, Pinglang Wang et al.

The prototypic cannabinoid type 1 (CB₁) receptor antagonist/inverse agonist, rimonabant, is comprised of a pyrazole core surrounded by a carboxyamide with terminal piperidine group (3-substituent), a 2,4-dichlorophenyl group (1-substituent), a 4-chlorophenyl group (5-substituent), and a methyl group (4-substituent). Previous structure-activity relationship (SAR) analysis has suggested that the...

Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Behavioural Pharmacology September 2011 Jenny L Wiley, D Matthew Walentiny, Robert E Vann et al.

Δ(9)-Tetrahydrocannabinol (THC) discrimination in rodents is a behavioral assay that has been used to probe differences among classes of cannabinoids in rats. The purpose of this study was to determine whether traditional and anandamide-like cannabinoids were distinguishable in cannabinoid discrimination procedures in mice. Male mice were trained to discriminate 30 mg/kg THC or 70 mg/kg...

The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.

European Journal of Pharmacology April 10, 2011 D Matthew Walentiny, Thomas F Gamage, Jonathan A Warner et al.

The endogenous cannabinoid system has been noted for its therapeutic potential, as well as the psychoactivity of cannabinoids such as Δ9-tetrahydrocannabinol (THC). However, less is known about the psychoactivity of anandamide (AEA), an endocannabinoid ligand. Thus, the goals of this study were to establish AEA as a discriminative stimulus in transgenic mice lacking fatty acid amide hydrolase...

Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug.

Pharmacological Reports 2011 Jenny L Wiley, Rhys L Evans, Darren B Grainger et al.

Adolescents and young adults of both sexes are the primary consumers of "club" drugs; yet, most of the mechanistic preclinical research in this area has been performed in adult male rodents. The purpose of this study was to evaluate the acute and repeated effects of drugs that are commonly abused by adolescents in female adolescent and adult rats in a rodent model of behavioral sensitization....

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.

Psychopharmacology June 1, 2010 D Matthew Walentiny, Robert E Vann, Jonathan A Warner et al. 49 citations

Salvinorin A, the primary psychoactive derivative of the hallucinogenic herb Salvia divinorum, is a potent and highly selective kappa-opioid receptor (KOR) agonist. Several recent studies, however, have suggested endocannabinoid system mediation of some of its effects. This study represents a systematic examination of this hypothesis. Salvinorin A was isolated from S. divinorum and was...

DOI: 10.1007/s00213-010-1827-6 (opens in new tab) Full text (opens in new tab) Salvinorin a Potent hallucinogen Kappa-opioid receptors Kappa-opioid pathway +7

Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.

European Journal of Pharmacology August 1, 2009 Robert E Vann, Jonathan A Warner, Kristen Bushell et al.

Primarily, rats have served as subjects in Delta(9)-tetrahydrocannabinol's (THC) discrimination studies although other species such as monkeys and pigeons have been used. While the introduction of the knockout and transgenic mice has vastly stimulated the study of the discriminative stimulus effects of drugs there is only a single published report of mice trained to discriminate THC. Thus, this...

Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats.

Addiction Biology September 2008 Jenny L Wiley, Rhys L Evans, Darren B Grainger et al.

Lifelong substance abuse is often initiated during adolescence; yet, most pre-clinical research in this area has been conducted in adult animals. Substantial evidence exists that the brain development that continues throughout adolescence may result in pharmacological responses that differ in a crucial manner from those of adults. The goal of this study was to evaluate age differences in motor...

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

Drug and Alcohol Dependence April 1, 2008 Robert E Vann, Thomas F Gamage, Jonathan A Warner et al.

Cannabis sativa (marijuana plant) contains myriad cannabinoid compounds; yet, investigative attention has focused almost exclusively on Delta(9)-tetrahydrocannabinol (THC), its primary psychoactive substituent. Interest in modulation of THC's effects by these other cannabinoids (e.g., cannabidiol (CBD)) has been stimulated anew by recent approval by Canada of Sativex (a 1:1 dose ratio...